Molecular formula: | C24H29N5O3 |
Average mass: | 435.528 |
Monoisotopic mass: | 435.227040 |
ChemSpider ID: | 5448 |
0 of 1 defined stereocentres
3-METHYL-2-(N-{[2′-(2H-1,2,3,4-TETRAZOL-5-YL)-[1,1′-BIPHENYL]-4-YL]METHYL}PENTANAMIDO)BUTANOIC ACID
3-methyl-2-[1-oxopentyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
N-Pentanoyl-N-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}valin
[German]
[ACD/IUPAC Name]N-Pentanoyl-N-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}valine
[ACD/IUPAC Name]N-Pentanoyl-N-{[2′-(1H-tétrazol-5-yl)-4-biphénylyl]méthyl}valine
[French]
[ACD/IUPAC Name]Valine, N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-
[ACD/Index Name]1089736-72-0
[RN]1089736-73-1
[RN]1331908-02-1
[RN]3-methyl-2-(N-{[2′-(1H-1,2,3,4-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl}pentanamido)butanoic acid
3-methyl-2-(pentanoyl{[2′-(1H-tetrazol-1-ium-5-yl)biphenyl-4-yl]methyl}amino)butanoate
3-methyl-2-(pentanoyl{[2′-(2H-tetrazol-2-ium-5-yl)biphenyl-4-yl]methyl}amino)butanoate
3-METHYL-2-[N-({4-[2-(2H-1,2,3,4-TETRAZOL-5-YL)PHENYL]PHENYL}METHYL)PENTANAMIDO]BUTANOIC ACID
3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid
3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoicacid
3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
3-Methyl-2-{pentanoyl-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
943333-68-4
[RN]Diovan
[Trade name]ent-valsartan
MFCD00865840
[MDL number]MFCD08060556
[MDL number]MFCD18252868
[MDL number]N-pentanoyl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}valine
N-pentanoyl-N-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}valine
Valsartan (CGP-48933)
Valsartan (JP17)
[USP] [INN]Valsartan-d3
Valsartan-d8
Valsartan-d9 (Major)